All Clinical Trials
Displaying results 1-10 of 3532
NCT01874236
VaReFi Validity and Reliability of Diagnostic Findings of SI Joint BlockingTERMINATED
SI Joint Pain
The purpose of the trial is to confirm the validity and reliability of diagnostic SI joint blocks.
SI-BONE, Inc.
NCT05252702
Aveir Dual-Chamber Leadless i2i IDE StudyACTIVE_NOT_RECRUITING
Cardiac Pacemaker, Artificial
Cardiac Rhythm Disorder
Bradycardia
Prospective, non-randomized, multi-center, international study designed to evaluate the safety and effectiveness of the Aveir™ Dual-Chamber (DR) Leadless Pacemaker system.
Abbott Medical Devices
NCT03010995
The Acute Cardiovascular Effects of Nicotine in E-cigarettes (ACE) StudyWITHDRAWN
Cigarette Smoking Toxicity
Nicotine
Acute Cardiovascular Disease
The goal of this project is to evaluate the nicotine induced acute cardiovascular changes in E-Cigarette users and also study the mechanism involved particularly with vascular impairment.
University of Louisville
NCT05740566
A Randomized, Open-label, Phase 3 Study of Tarlatamab Compared With Standard of Care in Subjects With Relapsed Small Cell Lung Cancer After Platinum-based First-line ChemotherapyACTIVE_NOT_RECRUITING
Small Cell Lung Cancer (SCLC)
The main objective is to compare the efficacy of tarlatamab with standard of care (SOC) on prolonging overall survival (OS).
Amgen
NCT01829477
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, 24-Week Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 50 mg Compared With Placebo as an Add-on to Glimepiride in Subjects With Type 2 DiabetesTERMINATED
Diabetes Mellitus, Type 2
The purpose of this study is to evaluate the effect of TAK-875 compared to placebo on glycemic control over a 24-week Treatment Period when used as an add-on to glimepiride in addition to diet and exercise.
Takeda
NCT03627091
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)TERMINATED
Crohn's Disease
The purpose of this study is to evaluate the efficacy and safety of ontamalimab as maintenance treatment in participants with moderate to severe Crohn's disease (CD).
Takeda
NCT03734536
Prospective Multi-center Study Comparing REGENETEN in Lieu of Standard Arthroscopic Repair of High-grade (>50%) Partial-thickness TearsTERMINATED
Arthroscopic Surgical Treatment of High-grade (>50%) Partialthickness
The goal of this clinical trial is to demonstrate that REGENETEN is superior to standard repair techniques when surgically treating high-grade (\>50%) partial-thickness tears.
Smith & Nephew, Inc.
NCT04133636
A Phase 2, Multicohort Open-Label Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple MyelomaRECRUITING
Multiple Myeloma
The purpose of this study is to evaluate the overall minimal residual disease (MRD) negative rate of participants who receive JNJ-68284528.
Janssen Research & Development, LLC
NCT04830124
A Phase 2, Open-Label, Multicenter, Cohort Study of Nemvaleukin Alfa (ALKS 4230) Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous Melanoma or Advanced Mucosal Melanoma - ARTISTRY-6TERMINATED
Cutaneous Melanoma
Mucosal Melanoma
This study observes the antitumor activity, safety, tolerability, PK, and pharmacodynamics in patients with inoperable and/or metastatic melanoma
Mural Oncology, Inc
NCT05995405
Safety and Tolerability of GTX-104 (Nimodipine Injection for IV Infusion) Compared with Oral Nimodipine in Patients Hospitalized for Aneurysmal Subarachnoid Hemorrhage (aSAH): a Prospective, Randomized TrialACTIVE_NOT_RECRUITING
Aneurysmal Subarachnoid Hemorrhage (aSAH)
The purpose of this study is to deliver nimodipine via IV directly into the bloodstream and to determine if this is as safe and tolerable as oral nimodipine capsules.
Grace Therapeutics Inc.